Alkem Labs to invest up to ₹533 crore in MP's Ujjain facility; gets 30-acre land allotmentAlkem Labs to invest up to ₹533 crore in MP's Ujjain facility; gets 30-acre land allotment

Introduction

Leading pharmaceutical firm secures 30 acres in Ujjain for new greenfield formulations facility, planning phased ₹533 crore investment to expand production capacity and strengthen operations.

Also Read: Varun Beverages expands footprint; Bevco acquires 100% of Crickley Dairy in South Africa, details here

Share price movement of Alkem Laboratories

On March 19, 2026, Alkem Laboratories Ltd opened at ₹5,331.60, down 0.32% from its previous close of ₹5,348.60. The stock reached a high of ₹5,333.75 (0.10%) and a low of ₹5,236.00. By 2:30 PM, it traded at ₹5,250.00, a 1.81% decrease, with a market cap of ₹62,769.23 crore.

Alkem Gets Ujjain Land Allotment

Alkem Laboratories has received an allotment letter from DMIC Vikram Udyogpuri Limited for 30 acres of land in Ujjain, Madhya Pradesh, to set up a greenfield formulations facility.

The Board of Directors approved an investment of up to ₹533 crore, to be deployed in a phased manner for the construction and operation of the new manufacturing facility.

The project aims to expand Alkem Laboratories’ production capacity and strengthen its pharmaceutical formulations operations. Details of the allotment and investment are available on the company website.

Stock performance of Alkem Laboratories for Period of 1 week, 6 months, and 1 year

Alkem Laboratories delivered a 1-week return of -1.70 percent, a 6-month return of -3.43 percent, and a 1-year return of 10.3 percent.

Also Read: Singer India gets NSE approval for listing of 6.22 crore equity shares; listing starting March 19

Shareholding Pattern of Alkem Laboratories

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	51.20	51.20%	53.00%
FII	10.00%	9.50%	9.10%
DII	21.50%	21.90%	21.80%
Public	17.30%	17.40%	16.10%

About Alkem Laboratories

Alkem Laboratories Ltd (NSE: ALKEM) operates globally in pharmaceuticals, focusing on development, manufacturing, and sale of pharmaceutical and nutraceutical products across multiple therapeutic segments worldwide.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

---